Empresa Haleon plc Nyse

Empresa Haleon plc Nyse

HLN

US4055521003

Farmacéuticos

Consenso de los analistas

Acciones

HLN

US4055521003

Farmacéuticos

Consenso de los analistas

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para Haleon plc

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Farmacéuticos - Otros

Resumen de negocios

Ventas por actividad

Ventas por región

Directores

Administradores

Clase de acciones

Accionistas

Información de la empresa

Empresas del grupo

Sector

Ventas por actividad

Ventas por región

Notaciones para Haleon plc

Revisiones del BPA

Beneficios trimestrales - Tasa de sorpresa

Sector Farmacéuticos - Otros

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 11/06/2024			Varia. Cinco días.	Varia. 1 de enero.
8,32 ^USD	-0,72 %		-0,72 %	+1,09 %

05/06	HALEON PLC : Berenberg Bank tiene una opinión positiva	ZM
05/06	Transcript : Haleon plc Presents at 21st Annual dbAccess Global Consumer Conference 2024, Jun-05-2024 04:30 PM

Haleon plc está especializada en la investigación, fabricación y comercialización de medicamentos y productos farmacéuticos de consumo. Las ventas netas se desglosan por familias de productos de la siguiente manera:
- productos para la salud bucal (27,7%; nº 1 mundial): Sensodyne, Parodontax, Polident, Biotene, marcas Aquafresh, etc;
- Medicamentos para aliviar el dolor (23,5%; nº 1 mundial): Panadol, Advil, Voltaren, marcas Excedrin, etc;
- Medicamentos para la salud digestiva (18,9%; nº 1 mundial): TUMS, Nicorette, ENO, Chap Stick, Fenistil, marcas Nexium, etc;
- medicamentos respiratorios (15,4%; nº 1 mundial): Theraflu, Otrivin, Flonase, marcas Contac, etc;
- vitaminas, minerales y complementos alimenticios (14,5%; nº 1 mundial): Marcas Centrum, Emergen-C, Caltrate, etc.
Las ventas netas se distribuyen geográficamente de la siguiente manera: Europa/Oriente Medio/África/América Latina (40,2%), América del Norte (37,1%) y Asia/Pacífico (22,7%).

Número de empleados: 25 408

GBP en millones	2022	Peso	2023	Peso	Delta
Oral Health 27,7 %	2 957	27,2 %	3 136	27,7 %	+6,05 %
Pain Relief 23,5 %	2 551	23,5 %	2 652	23,5 %	+3,96 %
Digestive Health and Other 18,9 %	2 096	19,3 %	2 138	18,9 %	+2,00 %
Respiratory Health 15,4 %	1 579	14,5 %	1 736	15,4 %	+9,94 %
Vitamins, Minerals and Supplements 14,5 %	1 675	15,4 %	1 640	14,5 %	-2,09 %

GBP en millones	2022	Peso	2023	Peso	Delta
EMEA and Latin America 40,2 %	4 270	39,3 %	4 545	40,2 %	+6,44 %
North America 37,1 %	4 116	37,9 %	4 195	37,1 %	+1,92 %
APAC 22,7 %	2 472	22,8 %	2 562	22,7 %	+3,64 %

Directores	Puesto	Edad	Desde
Brian McNamara CEO	Chief Executive Officer	57	22/07/21
Tobias Hestler DFI	Director of Finance/CFO	52	01/12/21
Franck Riot CTO	Chief Tech/Sci/R&D Officer	-	16/12/21
Sonya Ghobrial IRC	Investor Relations Contact	-	-
Tamara Rogers SAM	Sales & Marketing	-	16/12/21
Lisa Paley PRN	Corporate Officer/Principal	-	-
Keith Choy PRN	Corporate Officer/Principal	-	-
Filippo Lanzi PRN	Corporate Officer/Principal	-	-
Mairéad Nayager HRO	Human Resources Officer	-	01/03/22
Bjarne Tellmann LAW	General Counsel	57	16/12/21

Administradores	Puesto	Edad	Desde
Bryan Supran BRD	Director/Board Member	-	18/07/22
Dame Cox BRD	Director/Board Member	64	18/07/22
Tracy Clarke BRD	Director/Board Member	57	18/07/22
Vindi Banga BRD	Director/Board Member	69	18/07/22
Deirdre Mahlan BRD	Director/Board Member	61	18/07/22
David Lewis CHM	Chairman	59	23/05/22
David Denton BRD	Director/Board Member	59	01/03/23
Tobias Hestler DFI	Director of Finance/CFO	52	01/12/21
Brian McNamara CEO	Chief Executive Officer	57	22/07/21
Asmita Dubey BRD	Director/Board Member	-	18/07/22

	Vote	Quantity	Flotante	Autocontrol	Total Float
Acción A	1	9 132 301 104	7 461 224 253 ( 81,70 %)	0	81,70 %

Nombre	Acciones	%	Valoración
PFIZER, INC. 32,36 %	2 955 063 626	32,36 %	12 232 M $
GSK PLC 4,219 %	385 320 110	4,219 %	1 595 M $
Dodge & Cox 2,532 %	231 253 000	2,532 %	957 M $
The Vanguard Group, Inc. 2,405 %	219 663 000	2,405 %	909 M $
Norges Bank Investment Management 1,621 %	148 004 000	1,621 %	613 M $
MFS International (UK) Ltd. 1,389 %	126 851 728	1,389 %	525 M $
GIC Pte Ltd. (Investment Management) 1,045 %	95 442 000	1,045 %	395 M $
BlackRock Fund Advisors 1,009 %	92 189 000	1,009 %	382 M $
BlackRock Advisors (UK) Ltd. 0,9963 %	90 981 000	0,9963 %	377 M $
BlackRock Investment Management (UK) Ltd. 0,9364 %	85 518 000	0,9364 %	354 M $

Nombre	Acciones	%	Valoración
Dodge & Cox 3,875 %	176 953 251	3,875 %	1 493 M $
Fidelity Management & Research Co. LLC 1,835 %	83 806 041	1,835 %	707 M $
ClearBridge Investments LLC 0,8420 %	38 446 978	0,8420 %	324 M $
Fisher Asset Management LLC 0,3148 %	14 376 303	0,3148 %	121 M $
Wellington Management Co. LLP 0,2933 %	13 392 179	0,2933 %	113 M $
Citadel Securities GP LLC 0,2881 %	13 156 009	0,2881 %	111 M $
AllianceBernstein LP 0,2360 %	10 774 072	0,2360 %	91 M $
Merrill Lynch International 0,2319 %	10 590 597	0,2319 %	89 M $
RBC Private Counsel (USA), Inc. 0,1963 %	8 961 261	0,1963 %	76 M $
Aristotle Capital Management LLC 0,1946 %	8 887 558	0,1946 %	75 M $

Haleon Plc

The Heights Building 5, 1st Floor

KT13 0NY, Weybridge

+44 1932 822000

http://www.haleon.com

Nombre	Categoría y sector
GlaxoSmithKline Consumer Pvt Ltd. GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The company is based in Patiala, India and was founded in 2014.	Pharmaceuticals: Major
GlaxoSmithKline Consumer Healthcare Finance Ltd. GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare Holdings Ltd. GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.	Financial Conglomerates
Haleon UK Trading Services Ltd. Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The company is based in Weybridge, UK. Founded in 2012.	Drugstore Chains
GSK Consumer Healthcare Capital US LLC GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.	Medical/Nursing Services
Haleon UK Capital Plc Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara.	Regional Banks
Gsk Consumer Healthcare Capital Nl BV Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The company is located in the UK.	Pharmaceuticals: Other

Calificación trading

Calificación Inversor

ESG Refinitiv

Más Ratings

Venta

Compra

Recomendación promedio

ACUMULAR

Numero de análisis

Último precio de cierre

3,233 GBP

Precio objetivo promedio

3,646 GBP

Diferencia / Objetivo Promedio

+12,79 %

Consenso

Revisiones de las previsiones

La agenda de la empresa

	Varia. 1 de ene.	Capi.
ELI LILLY AND COMPANY	+48,53 %	779 mil M
NOVO NORDISK A/S	+40,67 %	631 mil M
JOHNSON & JOHNSON	-6,37 %	354 mil M
MERCK & CO., INC.	+20,93 %	333 mil M
ABBVIE INC.	+8,21 %	301 mil M
ASTRAZENECA PLC	+16,75 %	249 mil M
ROCHE HOLDING AG	-1,19 %	216 mil M
NOVARTIS AG	+10,85 %	214 mil M
AMGEN INC.	+4,40 %	163 mil M

Farmacéuticos - Otros

Farmacéutica e investigación médica

Farmacéuticos

Farmacéuticos

Farmacéuticos - Otros